PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 121 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $559,138 | -56.2% | 132,184 | -75.5% | 0.00% | -50.0% |
Q3 2022 | $1,276,000 | -53.4% | 538,544 | -43.9% | 0.00% | -33.3% |
Q2 2022 | $2,736,000 | -5.6% | 960,072 | -4.6% | 0.00% | 0.0% |
Q1 2022 | $2,898,000 | +29.5% | 1,005,983 | +36.7% | 0.00% | +50.0% |
Q4 2021 | $2,237,000 | +535.5% | 735,962 | +1364.0% | 0.00% | – |
Q3 2021 | $352,000 | -65.6% | 50,272 | -54.9% | 0.00% | -100.0% |
Q2 2021 | $1,024,000 | +31.3% | 111,506 | +39.0% | 0.00% | 0.0% |
Q1 2021 | $780,000 | +20.6% | 80,196 | +27.1% | 0.00% | – |
Q4 2020 | $647,000 | +9.5% | 63,109 | +7.8% | 0.00% | – |
Q3 2020 | $591,000 | -74.0% | 58,517 | -73.2% | 0.00% | -100.0% |
Q2 2020 | $2,277,000 | +46.3% | 218,311 | +18.4% | 0.00% | 0.0% |
Q1 2020 | $1,556,000 | -55.1% | 184,393 | -53.5% | 0.00% | -50.0% |
Q4 2019 | $3,466,000 | -0.9% | 396,119 | +22.0% | 0.00% | 0.0% |
Q3 2019 | $3,496,000 | -33.0% | 324,668 | -21.0% | 0.00% | -42.9% |
Q2 2019 | $5,221,000 | -72.8% | 410,800 | -17.0% | 0.01% | -72.0% |
Q1 2019 | $19,210,000 | +756.4% | 495,226 | +349.2% | 0.02% | +733.3% |
Q4 2018 | $2,243,000 | -83.7% | 110,235 | -63.3% | 0.00% | -81.2% |
Q3 2018 | $13,760,000 | -72.1% | 300,102 | -64.0% | 0.02% | -75.0% |
Q2 2018 | $49,304,000 | -48.8% | 833,544 | -41.1% | 0.06% | -51.1% |
Q1 2018 | $96,362,000 | -4.4% | 1,416,045 | +38.8% | 0.13% | -5.8% |
Q4 2017 | $100,836,000 | +504.4% | 1,020,078 | +632.2% | 0.14% | +434.6% |
Q3 2017 | $16,683,000 | -9.2% | 139,311 | -33.7% | 0.03% | -13.3% |
Q2 2017 | $18,369,000 | +324.5% | 210,168 | +80.7% | 0.03% | +275.0% |
Q1 2017 | $4,327,000 | +1445.4% | 116,309 | +1173.5% | 0.01% | – |
Q4 2016 | $280,000 | -92.8% | 9,133 | -84.2% | 0.00% | -100.0% |
Q3 2016 | $3,864,000 | -4.4% | 57,628 | -57.5% | 0.01% | 0.0% |
Q2 2016 | $4,043,000 | +42.1% | 135,727 | +40.1% | 0.01% | +16.7% |
Q1 2016 | $2,845,000 | -82.8% | 96,857 | -54.1% | 0.01% | -76.0% |
Q4 2015 | $16,533,000 | +188.5% | 210,870 | +177.3% | 0.02% | +212.5% |
Q3 2015 | $5,730,000 | +1946.4% | 76,032 | +3068.0% | 0.01% | – |
Q2 2015 | $280,000 | -98.7% | 2,400 | -97.3% | 0.00% | -100.0% |
Q1 2015 | $20,907,000 | +77.9% | 88,548 | +42.6% | 0.03% | +113.3% |
Q4 2014 | $11,750,000 | +39.3% | 62,080 | +75.6% | 0.02% | +25.0% |
Q3 2014 | $8,435,000 | +2901.8% | 35,355 | +731.3% | 0.01% | – |
Q2 2014 | $281,000 | -92.9% | 4,253 | -88.7% | 0.00% | -100.0% |
Q1 2014 | $3,932,000 | +80.9% | 37,758 | +79.9% | 0.01% | +100.0% |
Q4 2013 | $2,173,000 | +471.8% | 20,985 | +196.3% | 0.00% | +200.0% |
Q3 2013 | $380,000 | +18.4% | 7,083 | -2.1% | 0.00% | 0.0% |
Q2 2013 | $321,000 | – | 7,233 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |